GlucoTrack, Inc. (GCTK)

USD 0.23

(-5.78%)

Market Cap (In USD)

3.37 Million

Revenue (In USD)

-

Net Income (In USD)

-7.09 Million

Avg. Volume

17.27 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.201-4.95
PE
-
EPS
-
Beta Value
0.161
ISIN
US45824Q5071
CUSIP
45824Q507
CIK
1506983
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Paul V. Goode Ph.D.
Employee Count
-
Website
https://www.glucotrack.com
Ipo Date
2013-04-25
Details
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

More Stocks